Senate Passes F.D.A. Funding and ‘Right to Try’ Drug Bills

New York Times, August 3, 2017
by Robert Pear and Sheila Kaplan

WASHINGTON — The Senate on Thursday gave final approval to legislation to finance the Food and Drug Administration, clearing the measure for President Trump and tapping drug manufacturers once… Read More

A Landmark Lawsuit About An Intersex Baby’s Genital Surgery Just Settled For $440,000:

BuzzFeed News, July 26, 2017
by Azeen Ghorayshi

After four years in court, a first-of-its-kind legal battle over operating on “intersex” babies who are born with ambiguous genitalia has finally settled for $440,000, according to court… Read More

Hospitals Face Growing Cybersecurity Threats

NPR, July 26, 2017
by Lauren Silverman

In the neonatal intensive care unit of Cook Children's Hospital in Fort Worth, Texas, a father is rocking a baby attached to a heart monitor. While doctors roam the halls trying to prevent infections,… Read More

Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs

New York Times, July 25, 2017
by Katie Thomas

The pharmaceutical company Celgene has agreed to pay $280 million to settle claims that it marketed the cancer drugs Thalomid and Revlimid for unapproved uses, the company said on Tuesday.… Read More

NHS set to ban homeopathy for patients because it is ‘not evidence based [...]’

Independent, July 21, 2017
by Katie Forster

Doctors should stop prescribing homeopathic medicine to NHS patients, the health service has said. The change has been proposed because "at best, homeopathy is a placebo and a misuse… Read More

At a growing number of schools, sick kids can take a virtual trip to the doctor

STAT, July 19, 2017
by Leah Samuel

School nurses offer far more than just Band-Aids these days. As the prevalence of childhood conditions like asthma and diabetes have risen, nurses treat a wide range of problems. Still, only an estimated… Read More

Latinos Left Out Of Clinical Trials … And Possible Cures

Kaiser Health News, July 19, 2017
by Paula Andalo

[...] Cabrera is one of a relatively small number of Hispanics who participate in clinical trials. “Only less than 8 percent of enrollees are Hispanic, even though Hispanics comprise 17 percent of… Read More

Unapproved stem-cell treatments touted on federal database ClinicalTrials.gov, study says

Washington Post, July 19, 2017
by Laurie McGinley

Stem cell clinics offering unapproved treatments for ailments from hip pains to autism to erectile dysfunction increasingly are using a federal clinical-trials database as a marketing tool — a strategy… Read More

F.D.A. Deal Would Relax Rules on Reporting Medical Device Problems

New York Times, July 11, 2017
by Sheila Kaplan

WASHINGTON — Makers of cardiac defibrillators, insulin pumps, breast implants and other medical devices might be able to delay reporting dangerous malfunctions to the Food and Drug Administration… Read More

Medical Tourism, Medical Migration, and Global Justice: Implications for Biosecurity in a Globalized

Medical Law Review, April 11, 2017
by I. Glenn Cohen (Faculty Director)

From the paper: We live in the age of globalization. In medicine, that globalization has brought many benefits such as the diffusion of technology and the spread of health care training, but it has also… Read More

An FDA Commissioner for the 21st Century

NEJM, March 29, 2017
by Amitabh Chandra and Rachel E. Sachs (Academic Fellow Alumna)

President Donald Trump has named Scott Gottlieb as his nominee to be the next commissioner of the Food and Drug Administration (FDA). As compared with some of the other people whose names were floated… Read More

Travel Abroad for Low-Cost Care

Kiplinger's Personal Finance, December 6, 2016
by Miriam Cross, quoting I. Glenn Cohen (Faculty Director)

From the article: Why the extra effort to court foreign patients? A couple of reasons, according to Patients With Passports (Oxford University Press), by I. Glenn Cohen: to make money (from the… Read More

Senate committee calls for ban on surgeons conducting simultaneous operations

Boston Globe, December 6, 2016
by Jonathan Salzman and Jenn Abelson

From the article: A powerful Senate committee wants all hospitals to explicitly ban surgeons from overseeing two simultaneous operations, weighing in on a controversy that has roiled Massachusetts General… Read More

Is Medical Tourism Ethical?

The Greenwall Foundation, September 2016

Petrie-Flom Faculty Director I. Glenn Cohen served as a Greenwall Foundation Faculty Scholar, Class of 2015. The Greenwall Foundation recently published a profile of Cohen's project,… Read More

EpiPen’s Dominance Driven By Competitors’ Stumbles And Tragic Deaths

NPR, September 7, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow alumnus)

NPR recently called on Petrie-Flom Academic Fellow alumnus Nicholson Price to help explain how Mylan's Epi-Pen has come to dominate the market for epinephrine autoinjectors. From the article: … Read More

CALL FOR ABSTRACTS: 2017 Petrie-Flom Center Annual Conference
Harvard Law School

Deadline: Due no later than December 2, 2016

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is pleased to announce plans for our 2017 annual conference, entitled: “Transparency in Health and… Read More

FDA Regulations Limit Blood Donations From Gay Men

CBS San Francisco, June 14, 2016
by Holly Quan, featuring I. Glenn Cohen (Faculty Director)

Excerpt from the article: On World Blood Donation Day and in the wake of the Orlando mass shooting, a leading bioethicist Tuesday called for a change in the FDA’s policy regulating blood donations… Read More

After The Orlando Massacre, Many In The LGBTQ Community Are Turned Away From Giving Blood

Greater Boston (WGBH), June 14, 2016
by Nikki Blank, interviewing I. Glenn Cohen (Faculty Director)

Excerpt from interview: Early in the 1980's, there was a lifetime ban or deferral for any man who had ever had sex with another man. Even once. But in May, the FDA released new recommendations… Read More

Review: I Glenn Cohen, Patients with Passports: Medical Tourism, Law, and Ethics, Oxford University

Kennedy Institute of Ethics Journal, May 2016
by Reviewed by Douglas MacKay

From the review:  Glenn Cohen’s Patients with Passports: Medical Tourism, Law, and Ethics offers a thorough examination of the growing practice of medical tourism, the legal regulations… Read More

Assistant Professor of Medical Humanities
College of Medicine at University of Arkansas for Medical Sciences

Deadline: March 18, 2016

The Division of Medical Humanities in the College of Medicine at University of Arkansas for Medical Sciences (UAMS) seeks applicants for a tenure-track appointment as Assistant Professor of Medical… Read More

Robust Exclusion and Market Division Through Loyalty Discounts

Harvard Public Law Working Paper No. 14-12, April 2, 2015
by By Einer Elhauge (Founding Faculty Director) and Abe Wickelgren

Founding Faculty Director Einer Elhauge has coauthored an article Abe Wickelgren on loyalty discounts, which are often used in pharmaceutical and medical device markets. The article was awarded Best… Read More

Petrie-Flom Event Review:

Harvard Crimson, February 26, 2015
by Gabrielle M. Williams

There is a delicate balance between preserving individual rights and protecting public health when it comes to vaccines, experts argued at a panel discussion at Harvard Law School on Wednesday. [...] Panel… Read More

Patients with Passports: Medical Tourism, Law, and Ethics

Carnegie Council for Ethics in International Affairs, February 24, 2015
by Robert Klitzman, leading discussion with I. Glenn Cohen (Faculty Director)

Live Webstream Watch the event live online! Description Medical tourism is a growing, multi-billion dollar industry involving millions of patients who travel abroad each year to get health care. Some seek… Read More

Courts wrestle with wave of new state abortion laws

Politico, January 8, 2015
by Paige Winfield Cunningham, quoting I. Glenn Cohen (Faculty Director)

[...] As courts weigh the legal challenges to these laws, they’re being asked to spell out exactly how far states can go in regulating abortion and what requirements go too far. And states, particularly… Read More

F.D.A. Easing Ban on Gays, to Let Some Give Blood

New York Times, December 23, 2014
by Sabrina Tavernise, quoting I. Glenn Cohen (Faculty Director)

[...] “This is a major victory for gay civil rights,” said I. Glenn Cohen, a law professor at Harvard who specializes in bioethics and health. “We’re leaving behind the old view… Read More

Traveling patients, traveling disease

OUPblog, December 14, 2014
by I. Glenn Cohen (Faculty Director)

Many in the media and academia (myself included) have been discussing the Ebola crisis, and more specifically, the issues that arise as Ebola has traveled with infected patients and health care workers… Read More

Traveling Overseas for Medical Care

WOSU (NPR), December 10, 2014
by All Sides with Ann Fisher, interviewing I. Glenn Cohen (Faculty Director)

From the WOSU: All-inclusive vacations might feature a stay in a luxury hotel, gourmet meals, and in some cases, a hip replacement. Companies that specialize in medical tourism help patients in the… Read More

FDA Regulation of Mobile Health Technologies

NEJM, July 24, 2014
by Nathan G. Cortez, J.D., I. Glenn Cohen, J.D., and Aaron S. Kesselheim, M.D., J.D., M.P.H.

Petrie-Flom Faculty Director I. Glenn Cohen has published a new co-authored article in the New England Journal of Medicine on FDA regulation of new mobile health technologies. From the article: Medicine… Read More

Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men

JAMA, July 23, 2014
by I. Glenn Cohen, JD (Faculty Director); Jeremy Feigenbaum, JD; Eli Y. Adashi, MD, MS

Faculty Director I. Glenn Cohen has co-authored a new Viewpoint piece in the July 23/30, 2014 issue of JAMA, arguing for the end of the FDA's lifetime ban on blood donation by men who have sex with… Read More

Clinical Trials and the Right to Remain Silent

JAMA, July 21, 2014
by Michelle Mello, JD, PhD, MPhil and I. Glenn Cohen, JD (Faculty Director)

I. Glenn Cohen has coauthored a new Invited Commentary piece in JAMA on access to clinical trial data. From the article: In this issue of JAMA Internal Medicine, Kernan et al chronicle Yale University’s… Read More

Direct-to-Patient Laboratory Test Reporting

JAMA, June 16, 2014
by Michael J. Young, MPhil (Petrie-Flom Student Fellow); Ethan Scheinberg, BTL; Harold Bursztajn, MD

In February 2014, the Department of Health and Human Services (HHS) issued a landmark ruling allowing patients direct access to completed medical laboratory reports. The ruling took effect April 7,… Read More

Globalization and Healthcare Ethics

@BioethxChat, May 19, 2014
by I. Glenn Cohen (Faculty Director)

Join Petrie-Flom Faculty Co-Director I. Glenn Cohen on May 19 as he leads a discussion on "Globalization and Healthcare Ethics" hosted by BioethxChat on Twitter. Read More

FDA Advises Against Morcellator Use in Hysterectomies

Wall Street Journal, April 17, 2014
by Jon Kamp and Jennifer Levitz, quoting I. Glenn Cohen (Faculty Director)

[...] "The fact that the FDA released this warning makes it more likely that a doctor who went against it will be held to have practiced in a way below the standard of care," said I. Glenn Cohen,… Read More

VIDEO NOW AVAILABLE: Stem Cell Therapies:

Institute of Medicine, November 18, 2013
by Co-organized by I. Glenn Cohen

Stem cells hold tremendous potential to advance health and medicine. Through replacement of damaged cells and organs or supporting intrinsic repair, stem cell offer promising treatments for debilitating… Read More

Have Injury, Will Travel:

Outside Magazine, November 14, 2013
by Emily Matchar, quoting I. Glenn Cohen

[...] Most people who travel abroad for medical care are uninsured or underinsured, with high-copay or high-deductible insurance, says Glenn Cohen, a professor atHarvard Law School who studies… Read More